Nexalin Technology (NXL) Competitors $2.95 -0.53 (-15.23%) (As of 04:00 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXL vs. SKIN, KRMD, SGHT, LAKE, PDEX, NVRO, BWAY, SRTS, TLSI, and ZJYLShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include Beauty Health (SKIN), KORU Medical Systems (KRMD), Sight Sciences (SGHT), Lakeland Industries (LAKE), Pro-Dex (PDEX), Nevro (NVRO), BrainsWay (BWAY), Sensus Healthcare (SRTS), TriSalus Life Sciences (TLSI), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. Beauty Health KORU Medical Systems Sight Sciences Lakeland Industries Pro-Dex Nevro BrainsWay Sensus Healthcare TriSalus Life Sciences Jin Medical International Nexalin Technology (NASDAQ:NXL) and Beauty Health (NASDAQ:SKIN) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability. Is NXL or SKIN more profitable? Beauty Health has a net margin of -8.11% compared to Nexalin Technology's net margin of -3,407.98%. Beauty Health's return on equity of -44.83% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-3,407.98% -187.59% -167.21% Beauty Health -8.11%-44.83%-3.54% Does the MarketBeat Community believe in NXL or SKIN? Beauty Health received 39 more outperform votes than Nexalin Technology when rated by MarketBeat users. However, 50.00% of users gave Nexalin Technology an outperform vote while only 45.98% of users gave Beauty Health an outperform vote. CompanyUnderperformOutperformNexalin TechnologyOutperform Votes150.00% Underperform Votes150.00% Beauty HealthOutperform Votes4045.98% Underperform Votes4754.02% Does the media refer more to NXL or SKIN? In the previous week, Beauty Health had 14 more articles in the media than Nexalin Technology. MarketBeat recorded 15 mentions for Beauty Health and 1 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 1.43 beat Beauty Health's score of 0.79 indicating that Nexalin Technology is being referred to more favorably in the media. Company Overall Sentiment Nexalin Technology Positive Beauty Health Positive Do insiders and institutionals believe in NXL or SKIN? 0.7% of Nexalin Technology shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 24.0% of Nexalin Technology shares are held by company insiders. Comparatively, 41.0% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, NXL or SKIN? Nexalin Technology has higher earnings, but lower revenue than Beauty Health. Nexalin Technology is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$110K406.84-$4.65M-$0.64-5.44Beauty Health$398M0.50-$100.12M-$0.42-3.83 Which has more risk and volatility, NXL or SKIN? Nexalin Technology has a beta of 3.78, indicating that its stock price is 278% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Do analysts prefer NXL or SKIN? Nexalin Technology presently has a consensus target price of $3.00, indicating a potential downside of 13.79%. Beauty Health has a consensus target price of $2.55, indicating a potential upside of 58.39%. Given Beauty Health's higher possible upside, analysts plainly believe Beauty Health is more favorable than Nexalin Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Beauty Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryBeauty Health beats Nexalin Technology on 12 of the 17 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ ExchangeMarket Cap$44.75M$3.04B$6.83B$9.31BDividend YieldN/A1.73%2.96%4.06%P/E Ratio-5.4418.4445.8517.53Price / Sales406.8454.58485.99140.39Price / CashN/A39.9129.1437.95Price / Book8.093.755.664.92Net Income-$4.65M$90.26M$125.22M$225.78M7 Day Performance-17.54%-3.87%2.32%-1.58%1 Month Performance-10.54%2.12%8.89%6.67%1 Year Performance850.82%8.57%30.28%22.48% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology1.2356 of 5 stars$2.95-15.2%$3.00+1.7%+815.8%$37.94M$162,078.00-4.613Positive NewsSKINBeauty Health1.7615 of 5 stars$1.59+0.3%$2.55+60.9%-43.5%$196.73M$398M-3.761,030Gap UpKRMDKORU Medical Systems1.448 of 5 stars$4.29-0.2%$4.13-3.8%+74.6%$196.65M$28.52M-17.2080SGHTSight Sciences3.3512 of 5 stars$3.70+3.4%$5.12+38.4%+8.7%$187.81M$81.06M-3.51210LAKELakeland Industries4.6273 of 5 stars$23.61+4.0%$26.50+12.2%+40.2%$174.86M$151.82M-252.221,750Options VolumeNews CoveragePDEXPro-Dex2.6321 of 5 stars$48.80-1.3%$52.00+6.6%+195.6%$159.09M$53.84M32.10140NVRONevro2.2952 of 5 stars$4.21+3.4%$8.05+91.2%-81.3%$157.75M$425.17M-2.231,215Analyst ForecastNews CoverageBWAYBrainsWay4.1767 of 5 stars$9.43+0.1%$13.17+39.6%+61.3%$157.27M$38.63M95.20120SRTSSensus Healthcare4.1788 of 5 stars$8.00-2.0%$12.50+56.3%+224.2%$131.12M$24.41M14.3240Positive NewsTLSITriSalus Life Sciences4.0874 of 5 stars$3.95+1.0%$12.08+205.9%-54.9%$120.45M$26.89M-1.57106Analyst ForecastNews CoveragePositive NewsGap UpZJYLJin Medical InternationalN/A$0.77-0.4%N/A-97.4%$120.11M$19.82M0.00245 Related Companies and Tools Related Companies Beauty Health Alternatives KORU Medical Systems Alternatives Sight Sciences Alternatives Lakeland Industries Alternatives Pro-Dex Alternatives Nevro Alternatives BrainsWay Alternatives Sensus Healthcare Alternatives TriSalus Life Sciences Alternatives Jin Medical International Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
